OP004 The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitis

Authors :: Arezou Zargari
Thomas Knittel
Julia L. Ulmschneider
Charlotte Admyre
Raja Atreya
Heike Schmitt
MF Neurath
Ulrike Billmeier
Source :: Journal of Crohn's and Colitis. 12:S003-S004
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.

Subjects :: Agonist
biology
medicine.drug_class
business.industry
Gastroenterology
TLR9
General Medicine
medicine.disease
Ulcerative colitis
Anti-inflammatory
Immunology
medicine
biology.protein
Cell response
Colitis
Interleukin 6
business

Full Text Access

Tools